|Abstract||Aims: This guidance offers recommendations on the diagnostic tests, treatment regimens and health promotion principles needed for the effective management of pelvic inflammatory disease (PID). It covers the management of the initial presentation, as well as how to reduce transmission and future infection.|
Intended audience: Women aged 16 years+ (see specific guidelines for those under 16) presenting to healthcare professionals working in STI departments offering level 3 care within the UK.
Publication date: First published 2002, revised and updated February 2005.
- consider removal of an intra uterine contraceptive in a woman with a diagnosis of PID
- metronidazole may be discontinued in women with mild to moderate PID who cannot tolerate it
- in women at high risk of gonococcal PID a cephalosporin based regimen is preferred to the use of a quinolone